NLS Insight’s goal is to assist the Nordic regions leading innovators in targeting business collaborations, partnership opportunities and investment potential.

Bulletin from Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals

The Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) took place on Thursday, May 24, 2018 in the company´s premises at Tomtebodavägen 23a in Stockholm, Sweden.

Global Pharma Consulting participates in Swecare Foundation’s 40th anniversary

Global Pharma Consulting

Global Pharma Consulting was pleased to be a part of the recent celebrations at the Swecare Foundation, marking their 40 year anniversary.

SpagoPix shows good safety in regulatory preclinical studies

Spago Nanomedical

Spago Nanomedical AB (publ) has completed the in-life part of the regulatory preclinical program with SpagoPix. The product candidate SN132D displays a good safety margin to clinically relevant doses.

IMBRUVICA® (ibrutinib) Plus GAZYVA® (obinutuzumab) Phase 3 iLLUMINATE Trial for First-Line Therapy of Chronic Lymphocytic Leukemia (CLL) Patients Met Primary Endpoint

AbbVie to Present at the Jefferies 2018 Global Healthcare Conference

AbbVie will participate in the Jefferies 2018 Global Healthcare Conference on Wednesday, June 6, 2018. Bill Chase, executive vice president and chief financial officer, will present at 7:30 a.m. Central time.

AbbVie Donates $100 Million to Strengthen Access to Healthcare, Housing for Hurricane-Ravaged Puerto Rico

Partners Direct Relief and Habitat for Humanity International will focus on rebuilding primary healthcare system and ensuring access to affordable, disaster-resilient housing, respectively

Birka BioStorage and Bjornstorps Gods cut the first sod for the new biorepository facilities in Lund

Birka BioStorage

Today Birka BioStorage and Bjornstorps Gods take the first step towards preparing to set up the biggest biorepository for research material in Europe.

Spago Nanomedical is recruiting!

Spago Nanomedical

Spago Nanomedical is recruiting another chemist: We offer challenging chemical problems in the area of nanomedicine for a PhD-level scientist who thrives on solving them.

Head-to-head pharmacokinetic study demonstrated greater factor IX activity with Rebinyn® versus rFIXFc in people with hemophilia B

Novo Nordisk

A new head-to-head pharmacokinetic study showed that adults with hemophilia B who received a single dose (50 IU/kg) of Rebinyn® [Coagulation Factor IX (Recombinant), GlycoPEGylated] achieved high factor IX activity for longer than those treated with rFIXFc [Coagulation Factor IX (Recombinant), Fc Fusion Protein].

Neal Greenspan will lead the MatchIT project connecting IT talent to companies

Ideon Science Park

Ideon Science Park is happy to tell you that we have a new member in our team! Since early March, Neal Greenspan has been leading the EU funded project called MatchIT.

AbbVie to Show Progress and Growth in Oncology Research at the American Society of Clinical Oncology 2018 Annual Meeting

More than 30 abstracts accepted across hematologic malignancies, solid tumors and other oncology-related diseases

InDex Pharmaceuticals Holding AB (publ) interim report January – March 2018

InDex Pharmaceuticals

Novel formulation for oral administration of cobitolimod

How to use the value tree to communicate the right values to your customers

Ideon Science Park